A POTENTIAL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a dangerous brain malignancy known for its fast growth and resistance to typical treatments. Research are constantly underway to identify new treatment strategies, and recently, a novel biomarker named LCA168 has emerged as a potential target for glioblastoma treatment. LCA168 is a protein that is abundantly produced in glioblastom